GENEVA (AP) — The fall in the U.S. dollar value last year cost UEFA about $55 million. The dollar value dropped about 9% against a range of foreign currencies in the first months of 2025, which economists linked to investors’ waning confidence in the U.S. under President Donald Trump, who returned to office last January. UEFA cited “economic, market and geopolitical dynamics” and a “sudden weakening of the U.S. dollar” for driving the foreign exchange losses which accounted for the loss in its accounts ...

by the CME with the news and the number. >> Yes. Jobless claims uh for the week of December 20th and that's ending December 20th on initial claims.214,000 well below the 225,000 we're expecting 214,000 would be the lowest since well the last week in November when it was 192,000 and that was the lowest going back to 22 at 189 which was the lowest since the 1960s. So we are definitely under 225ish are considered ultra low. And if we look at continuing claims after a couple of weeks of being under 1.9% million ...

Financial Performance & Guidance - Q3 2025 revenue was $353 million, a decrease of $48 million compared to Q3 2024[39] - Adjusted EBITDA for Q3 2025 was $42 million, down $9 million from Q3 2024[39] - The company projects Q4 2025 Adjusted Free Cash Flow to be between $25 million and $30 million[39] - 2025 Adjusted EBITDA guidance is $135-140 million[39] Segment Performance - Cellulose Specialties Q3 2025 Adjusted EBITDA was $66 million with a 32% margin[39, 40] - Biomaterials Q3 2025 Adjusted EBITDA was $1 million with a 13% margin[39, 45] - Cellulose Commodities Q3 2025 Adjusted EBITDA was negative $3 million with a negative 4% margin[39, 48] - Paperboard Q3 2025 Adjusted EBITDA was $1 million with a 3% margin[39, 54] - High-Yield Pulp Q3 2025 Adjusted EBITDA was negative $9 million with a negative 38% margin[39, 60] Strategic Initiatives - The company aims to restore Temiscaming profitability with $10 million annual EBITDA improvement through cost reduction and $10 million annual EBITDA improvement by improving Paperboard Operational Equipment Efficiency (OEE)[20] - The company expects Biomaterials to contribute approximately $31 million of proportional run-rate EBITDA in 2027 and approximately $80 million including proportional AGE EBITDA in 2028[34]

They've got a few things on their plate. One is they're looking to do a big fiscal expansionary budget that typically leads to a stronger currency because you're boosting your growth. But they usually need the central bank to raise rates in response to this.And that's the problem. There's a slight political lie in the markets pricing for the BBJ with the new prime minister, the first woman to ever lead Japan in that role, making it clear her views in the past about the BOJ being foolish to raise rates. And ...

Core Insights - The focus for the upcoming week will be on developments regarding the U.S. government shutdown [1] - The minutes from the last Federal Reserve meeting, scheduled for Wednesday, are expected to draw significant attention [1] Group 1 - The U.S. government shutdown remains a critical issue that could impact various sectors and market sentiment [1] - The Federal Reserve's meeting minutes will provide insights into monetary policy and economic outlook, influencing investor decisions [1]

Core Viewpoint - South Korea's negotiations with the U.S. on a trade deal to lower tariffs have stalled due to concerns over the foreign exchange implications of a $350 billion investment fund [1] Group 1: Trade Deal Context - South Korean officials argue that the investment package would primarily consist of loans and guarantees rather than direct investments, which they cannot accept under terms similar to Japan's $550 billion investment package [2] - The U.S. has stated that there will be no flexibility for South Korea, emphasizing that they must either accept the deal or face tariffs [3] Group 2: Currency Market Concerns - There are worries that the dollar demand resulting from the investment deal will overwhelm the domestic currency market, potentially depressing the won [4] - South Korea's daily average global won trade was $142 billion in 2022, significantly lower than Japan's $1.25 trillion for the yen, indicating a smaller market share for the won [5] Group 3: Economic Implications - The won reached a 15-year low at approximately 1,476 to the dollar at the end of last year and is currently around 1,390, with market participants noting that the state pension fund's $40 billion annual overseas investment requirement is a burden on the currency [6] - South Korea's economy is smaller than Japan's, with a current account surplus of $99 billion last year compared to Japan's nearly $200 billion, and foreign reserves of $416 billion versus Japan's $1.3 trillion [7]

Core Viewpoint - The United States and Japan reaffirmed their commitment to market-determined exchange rates while agreeing that foreign exchange interventions should be reserved for combating excess volatility [1][3][4] Group 1: Exchange Rate Commitments - The U.S. Treasury Department and the Japanese Finance Ministry emphasized that exchange rates should be market determined and that excess volatility can adversely affect economic stability [3] - Both countries reconfirmed that they have avoided exchange rate interventions for competitive trade advantages, implicitly approving Japan's yen-buying actions in 2022 and 2024 as not being unfair manipulation [4] Group 2: Bilateral Relations - The latest agreement did not include new demands from the Trump administration regarding foreign exchange, providing Japan with some relief in navigating bilateral ties with the U.S. [2][7] - Finance Minister Katsunobu Kato indicated that the joint statement reflects discussions with U.S. Treasury Secretary Scott Bessent as part of broader trade negotiations [5] Group 3: Tariff Negotiations - The U.S. will reduce tariffs to 15% on most Japanese imports in exchange for Japan's $550 billion investment package directed towards the U.S., which includes government-backed loans and guarantees [6] - The foreign exchange market showed little immediate reaction to the joint statement [6]

Solana's Vision - Solana aims to host every asset and market on a single, globally distributed state machine, synchronized at the speed of light [2] - Solana envisions the emergence of internet capital markets [2] Market Scope - Solana targets a wide array of financial instruments, including stocks, bonds, lending, money markets, foreign exchange, commodities, derivatives, private equity, venture capital, hedge funds, real estate investment trusts, asset-backed securities, municipal bonds, treasury securities, corporate bonds, convertible bonds, preferred stocks, common stocks, options, futures, swaps, credit default swaps, mortgage-backed securities, collateralized debt obligations, exchange-traded funds, mutual funds, index funds, closed-end funds, unit investment trusts, American depositary receipts, global depositary receipts, warrants, rights offerings, initial public offerings, secondary offerings, private placements, repurchase agreements, commercial paper, certificates of deposit, banker's acceptances, Eurodollars, currency forwards, interest rate swaps, equity swaps, total return swaps, structured products, contingent convertible bonds, green bonds, Sukuk, catastrophe bonds, inflation-protected securities, zero-coupon bonds, and floating rate notes [1]

Financial Data and Key Metrics Changes - The company reported a 14% growth in adjusted EBITDA and a 16% growth in adjusted earnings per share for Q1 2025, both excluding reportable catastrophes [5][19] - The holding company liquidity position remained solid at over $500 million at quarter end, with over $100 million returned to shareholders, including $62 million in share repurchases [20] Business Line Data and Key Metrics Changes - In Global Lifestyle, adjusted EBITDA was down 5% compared to last year, impacted by unfavorable foreign exchange and a prior year one-time client contract benefit [21] - Global Automotive saw stable adjusted EBITDA, with improved loss experience offsetting lower investment income [23] - Global Housing achieved a 31% increase in adjusted EBITDA to $269 million, excluding catastrophes, driven by significant policy growth and favorable non-catastrophe loss experience [24] Market Data and Key Metrics Changes - The homeowners business experienced a 17% top-line growth, primarily due to the addition of 70,000 lender-placed policies [12] - The renters business added over 250,000 policies through a new renter's book, contributing to double-digit written premium growth in the property management company channel [13][68] Company Strategy and Development Direction - The company is focused on executing and optimizing partnerships across lifestyle and housing, with significant investments in new programs and clients [6][16] - The strategy emphasizes a differentiated B2B2C distribution model, aiming to leverage competitive advantages and financial performance [15] - The company plans to continue expanding offerings with existing clients and entering adjacent sectors through new product launches [16] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving the ninth consecutive year of earnings growth in 2025, despite macroeconomic uncertainties [16][29] - The company is closely monitoring the impact of tariffs and macroeconomic conditions on claims costs and consumer demand, with a belief that the business model can navigate these challenges [17][29] Other Important Information - The company was recognized by the American Red Cross as a 2025 disaster relief hero for its support during 2024 storms [12] - The 2025 catastrophe reinsurance program was successfully placed, increasing coverage at more attractive terms [26] Q&A Session Summary Question: Update on Global Lifestyle loss ratio and improvement expectations - Management acknowledged the high loss ratio and indicated ongoing efforts in Global Auto to drive improvements, with encouraging trends in loss experience [33][37] Question: Size and cadence of investments in Connected Living - Management confirmed continued investments similar to previous years, with a focus on new client launches and capabilities [39][40] Question: Impact of tariffs on guidance - Management indicated that tariffs are expected to have manageable impacts, particularly in auto and housing, and that the business is well-positioned to navigate these challenges [45][46] Question: Expense ratio impact from catastrophe losses - Management noted that the expense ratio was impacted by higher reinsurance costs and claims management expenses, but underlying expenses remained flat year over year [52][53] Question: Financial impact of Total Wireless by Verizon - Management clarified that the program is a new launch, starting from customer one, and will ramp up over three to four years [60][61] Question: Trends in lender-placed business and voluntary insurance market - Management confirmed continued growth in lender-placed policies, particularly in California and the Midwest, indicating ongoing demand [63][65] Question: Trade-in dynamics and customer behavior - Management noted that customers are keeping devices longer, but promotional activity also influences demand, with competitive intensity expected to drive growth [66][67] Question: Growth in renters business and new customer acquisition - Management highlighted the strategic acquisition of 250,000 policies and ongoing double-digit growth in the property management channel [68][70]

Core Viewpoint - AbbVie's stock price has seen a positive momentum following its first-quarter earnings report, outperforming the S&P 500 index due to bullish analyst notes [1]. Group 1: Analyst Recommendations - BMO Capital's analyst Evan David Seigerman maintained an "outperform" recommendation for AbbVie with a price target of $215 per share [2]. - HSBC highlighted AbbVie as a good value investment amidst downgrades of other healthcare stocks, indicating a positive outlook for the company [5]. Group 2: Earnings Performance - AbbVie's first-quarter earnings report showed strong performance, particularly from high-revenue products Skyrizi and Rinvoq, which compensated for expected declines in Humira sales [3]. - The company raised its per-share earnings guidance, which was viewed positively by analysts [4]. Group 3: Market Context - AbbVie's stock gained over 3% during the trading session, contrasting with the S&P 500's less than 0.1% gain, indicating strong investor confidence [1].